Medrio

🔑 Implementing #ePRO sets off a chain reaction for participants and sponsors. ePRO is more convenient for participants to use than traditional paper methods. ➡️ Convenience leads to better compliance and more consistent data entry. ➡️ Compliance and consistency means sponsors get complete, accurate data in real time while adhering to protocol schedules. Curious about the advantages of ePRO? Read our paper vs. ePRO guide, featuring Medrio’s VP of eClinical Solutions and Consulting, Melissa Newara: https://bit.ly/3xNUVoy #PatientCentricity #DataQuality #ClinicalTrials #ClinicalDataManagement

📩 The results of our latest survey with BioPharma Dive are in! Emerging #biopharma, #biotech, and #CRO decisions-makers seem most excited about improvements in data reliability. They also reported data reliability as a top benefit of a technology-backed future. See what aspects of clinical trial technology are working for biopharma and CRO decision-makers, and what aspects could use optimization.  Read the survey report: https://bit.ly/4bYxKGU

🗓️ The July Edition of Medrio's Resource Roundup is here! Look back at Medrio's most popular resources from the past month to learn: ✅ How emerging biotech and CRO organizations are using eClinical technology in their clinical trials and other trends from our survey report. ✅ Why proactive guidance is so important for emerging organizations as they look to overcome staffing challenges and navigate growth phases. ✅ How early-phase oncology sponsors can benefit from a fully integrated CDMS/EDC solution, from supporting mid-study changes to meeting the push for Real-Time Oncology Review (RTOR). #EDC #CDMS #Oncology #Biotech #CRO #DataQuality #ClinicalDataManagement #ClinicalTrials

📈 As your clinical trials grow, so do regulatory, resource, and time pressures that can prevent you from scaling efficiently. Our webinar featuring Nicole Latimer and Roche Diagnostics' Khone Saysana and Walter S. dives into strategic eClinical solutions that can help you scale with ease.  Watch it on-demand today: https://bit.ly/45NQJS2

Don’t risk decision-making delays in your clinical trials! Make the switch to ePRO for: 📲 Immediate access to patient-reported outcome data 📨 Less data reconciliation and manual entry ⏰ Prompt identification of issues and missing data Discover how ePRO can transform your clinical data collection processes with our guide: https://bit.ly/3XJ0yyQ #ePRO #DataQuality #ClinicalDataManagement #PatientCentricity

🔴 Excessive querying in your clinical trials? Let’s fix that!  Wrong dates and missing data are going to happen. However, poorly built queries can be a headache for your site staff, especially when less than 2% of queried data actually changes. How can a robust CDMS/EDC system help researchers be more efficient in collecting, protecting, and preserving their data without disrupting workflows? See at-a-glance in our infographic: https://bit.ly/4bq9i04 #DataQuality #EDC #CDMS #ClinicalTrials #ClinicalDataManagement

As your team grows, so do your training needs and onboarding costs–obligations that can quickly deplete resources. For non-oncology studies, the number of FTE employees can multiply five times from Phase I to Phase III*. Emerging companies can create a streamlined, repeatable training process that conserves resources by choosing an CDMS/EDC partner with: ↪️ A short learning curve ✍️ Proven implementation and onboarding plans 🧑💻 Responsive teams that provide hands-on training 🎓 Complimentary support for new features Get ready to scale with our latest strategic guide for emerging companies from Charles G. and other Medrio experts: https://bit.ly/3XjTrN5 *Source: Tufts CSDD Impact Report March-April 2022

The Human Genome Project set the stage for gene therapy's rapid growth. Now, with the #FDA approving 10 to 20 cell and gene therapies per year, the possibilities seem endless. Researchers are inspired to tread into new frontiers that support innovation, such as artificial intelligence (AI). These AI breakthrough include: 🔎Algorithms that enhance the identification of potential gene targets. 🎯Machine learning models that analyze vast genomic datasets to pinpoint patterns. 💭AI-driven platforms that can predict treatment outcomes. Learn more about the scientific and technological breakthroughs shaping the gene therapy landscape: https://bit.ly/3QyFBSY

📊According to our recent survey of small biopharmas, biotechs, and CROs, feelings around clinical trial technologies are generally optimistic, but there's concern for the future. Respondents feel their existing tech might struggle to keep up. Increasingly complex clinical trial elements, such as synthetic control arms and hybrid/fully decentralized trials, were especially concerning. Discover critical findings that could influence your technology strategy in our survey report: https://bit.ly/4esIiiX #Biotech #CRO #ClinicalTrials #DataQuality #RealWorldData

Delays in oncology research can have dire consequences – participant lives could be at stake. Early phase oncology sponsors need to keep their study timelines on track, and a fully integrated CDMS/EDC solution could be the key. ⭐ Revisit our blog to see how a fully integrated tech stack can support mid-study protocol changes and meet the regulatory push for Real-Time Oncology Review (RTOR): https://bit.ly/4biu4P4 #ClinicalTrials #ClinicalDataManagement #EDC #ePRO #eConsent #RTSM #Oncology #ClinicalTrials #PatientCentricity